Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Case Report

RMJ. 2016; 41(4): 511-513

Postoperative residual curarization after sugammadex reversal following a prolonged rocuronium infusion

Jeong Han Lee.

A 48-year-old male patient underwent robot-assisted radical cystectomy and neobladder formation under general anesthesia. He received a continuous infusion of rocuronium bromide to induce profound neuromuscular blockade during the operation. Sugammadex was injected for the reversal of neuromuscular blockade but the patient developed respiratory arrest in 30 minutes in ICU. He was reintubated and injected additional sugammadex. After improvement he was extubated, moved to the general ward the following day and was discharged without any further complications.

Key words: neuromuscular blockade, rocuronium, sugammadex.

Similar Articles

Three-dimensional models of neuromuscular tissue.
Raffa P, Easler M, Urciuolo A
Neural regeneration research. 2022; 17(4): 759-766

Ultra-early amplitude decrement after repetitive nerve stimulation supports early neuromuscular junction injury in amyotrophic lateral sclerosis: a prospective cross-sectional study.
Ma JY, Liu XY, Zhang S, Fan DS
Neural regeneration research. 2022; 17(3): 655-660

Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy.
Chen J, Fang H, Hu Y, Wu J, Zhang S, Feng Y, Lin L, Tian H, Chen X
Bioactive materials. 2022; 7(): 167-180

PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects.
D'Alessio A, Rimassa L, Cortellini A, Pinato DJ
Journal of hepatocellular carcinoma. 2021; 8(): 887-897

Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.
Krueger J, Santinon F, Kazanova A, Issa ME, Larrivee B, Kremer R, Milhalcioiu C, Rudd CE
PloS one. 2021; 16(6): e0251731

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites